The Role of Biomaterials in Treating Peripheral Nerve Injury
Peripheral nerve injury (PNI) remains a significant medical challenge due to its slow recovery process and complex clinical outcomes. When a nerve is damaged, prolonged denervation can lead to muscle atrophy and reduced Schwann cell activity, both critical for axonal regeneration. In response, innovative approaches such as biomaterial-based implants have emerged as promising solutions to accelerate nerve recovery.
While drugs like ibuprofen have shown potential in promoting nerve regeneration through anti-inflammatory properties, systemic administration often causes unwanted side effects. To overcome this, electrospinning in the biomedical field has gained traction as a method for delivering drugs directly to the injury site via polymer-based scaffolds. Recently, the University College London School of Pharmacy published a study in which the team developed ibuprofen-loaded electrospun materials suitable for surgical implantation in peripheral nerve injuries using our Fluidnatek LE-50 G2 equipment.
What is Electrospinning and Why is it Ideal for Nerve Recovery?
Electrospinning is a versatile technique that transforms polymer solutions into fine, nano- to micro-scale fibers by applying a high-voltage electric field. These fibers are collected into mats that mimic the extracellular matrix of tissues, making them ideal candidates for biomedical applications, especially in nerve repair.
The advantages of electrospun materials include:
- Customizability: Physical properties like mechanical strength and drug release rates can be tuned.
- Biocompatibility: Synthetic polymers such as polycaprolactone (PCL) and polylactic acid (PLA) are widely used due to their compatibility with biological systems.
- Sustained Drug Release: Electrospun fibers can encapsulate drugs like ibuprofen, ensuring controlled and prolonged release at the target site.
For peripheral nerve injury, electrospun wraps or implants loaded with therapeutic agents significantly enhance the healing process by delivering localized treatment, minimizing side effects.
Electrospinning and Ibuprofen Delivery for Nerve Recovery
Recent advancements have demonstrated the successful development of ibuprofen-loaded electrospun biomaterials for peripheral nerve injury. Ibuprofen, a widely used non-steroidal anti-inflammatory drug (NSAID), is known to improve nerve regeneration by inhibiting inflammatory responses and promoting neurite growth.
In a cutting-edge study, researchers optimized the use of electrospun nerve wraps fabricated from PCL, PLA, and their copolymers. The following findings underscore the potential of these polymer-based implants:
- Optimized Fiber Properties: Electrospinning parameters were tuned to produce smooth, defect-free fibers with varying diameters. The incorporation of ibuprofen into these fibers allowed for a controlled, sustained release over 21 days.
- Surgical Handling: User evaluations highlighted the importance of mechanical properties, with PLA/PCL (70/30) blends demonstrating superior flexibility and strength, making them ideal for nerve-wrapping applications.
- In Vivo Performance: In animal models, ibuprofen-loaded electrospun materials accelerated nerve regeneration. Axon counts in treated nerves were significantly higher compared to controls, confirming the therapeutic effect of localized ibuprofen delivery.
Photographs showing stages of electrospun material implantation procedure in a rat sciatic nerve crush model.
Polymer Selection in Electrospinning for Biomedical Implants
The success of electrospun biomaterials depends heavily on the choice of polymers. For peripheral nerve injury, polymers must exhibit biocompatibility, biodegradability, and mechanical stability. The following polymers are commonly employed:
- Polylactic Acid (PLA): Known for its slow degradation rate, PLA provides a robust structure but can be brittle.
- Polycaprolactone (PCL): Offers excellent flexibility and strength, ideal for implants requiring pliability.
- PLA/PCL Copolymers: Combining the strengths of PLA and PCL, these copolymers achieve the desired balance of mechanical stability and handling ease.
In the case of ibuprofen-loaded electrospun implants, PLA/PCL (70/30) was identified as the most suitable formulation due to its superior surgical handling and sustained drug release profile.
Summary of formulation properties. Scanning electron micrographs (A) reveal cylindrical fibres with no visible defects. A histogram of fibre diameters (B) shows unimodal distribution for all tested formulations. Cumulative ibuprofen release data (C) present an initial burst release followed by a period of sustained release over 21 days (Each formulation was tested in triplicate, and the results are presented as mean ± SEM (n = 3)).
The Future of Electrospun Biomaterials in Nerve Repair
As research in the biomedical field advances, electrospinning continues to demonstrate immense potential for improving outcomes in nerve injuries. Key areas of future development include:
- Scalable Manufacturing: Ensuring that electrospun materials can be mass-produced for clinical use.
- Advanced Drug Loading: Incorporating multiple therapeutic agents for synergistic effects on nerve regeneration.
- Clinical Trials: Translating promising in vivo results into human applications to validate the efficacy and safety of electrospun biomaterials.
Conclusion
The use of electrospinning in the biomedical field has revolutionized the development of drug-loaded implants for peripheral nerve injury. By leveraging polymers such as PLA and PCL, researchers have created biomaterials capable of delivering sustained, localized treatment, accelerating nerve regeneration and functional recovery.
Ibuprofen-loaded electrospun fibers represent a significant advancement in nerve recovery strategies, offering a targeted, effective, and minimally invasive solution. As the field continues to evolve, these innovative biomaterials hold the promise of transforming peripheral nerve injury treatment and enhancing patient outcomes.
References
Karolina Dziemidowicz, Simon C. Kellaway, Owein Guillemot-Legris, Omar Matar, Rita Pereira Trindade, Victoria H. Roberton, Melissa L.D. Rayner, Gareth R. Williams, James B. Phillips,
Development of ibuprofen-loaded electrospun materials suitable for surgical implantation in peripheral nerve injury,
Biomaterials Advances,
Volume 154, 2023, 213623,
ISSN 2772-9508,
*All images in the article are the property of the authors.
ESP